With the objective of reducing drug side effects and saving lives, Rejuvenics Technologies is structured around the creation of a drug--delivery ystems that directs cancer therapies directly at the tumor. A startup coming out of the University of Arkansas, Fayetteville, continuing work by Rejuvenics Technologies on development of the technology wilh also involved personnel from University of Arkansas for Medical Sciences
